Here's What Analysts Are Forecasting For Vidrala, S.A. (BME:VID) After Its Interim Results

The interim results for Vidrala, S.A. (BME:VID) were released last week, making it a good time to revisit its performance. It was a credible result overall, with revenues of €830m and statutory earnings per share of €7.23 both in line with analyst estimates, showing that Vidrala is executing in line with expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

See our latest analysis for Vidrala

earnings-and-revenue-growth
BME:VID Earnings and Revenue Growth July 27th 2024

Following the recent earnings report, the consensus from twelve analysts covering Vidrala is for revenues of €1.60b in 2024. This implies a small 5.4% decline in revenue compared to the last 12 months. Statutory earnings per share are predicted to surge 22% to €8.48. In the lead-up to this report, the analysts had been modelling revenues of €1.60b and earnings per share (EPS) of €8.52 in 2024. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

It will come as no surprise then, to learn that the consensus price target is largely unchanged at €115. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic Vidrala analyst has a price target of €130 per share, while the most pessimistic values it at €96.00. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.

Of course, another way to look at these forecasts is to place them into context against the industry itself. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 11% by the end of 2024. This indicates a significant reduction from annual growth of 13% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 4.2% per year. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Vidrala is expected to lag the wider industry.

Advertisement

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Vidrala's revenue is expected to perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on Vidrala. Long-term earnings power is much more important than next year's profits. We have estimates - from multiple Vidrala analysts - going out to 2026, and you can see them free on our platform here.

You can also view our analysis of Vidrala's balance sheet, and whether we think Vidrala is carrying too much debt, for free on our platform here.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

M
mitchell_lawler
mitchell_lawler

Berkshire sold Visa and Mastercard. Ackman just bought both. So whose "smart money" are you actually following?

137
m
marcus_l38oa

American Express is the bigger bet of Buffet than Mastercard and Visa. They are still holding it.

z
zoe_vi5fn

lol. what we should be discussing is Berkshire's cash pile. Close to 400 billion now.

Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
85

About BME:VID

Vidrala

Engages in the manufacture and sale of glass containers for food and beverage products in the United Kingdom, Ireland, Italy, Iberian Peninsula, rest of Europe, and Brazil.

Excellent balance sheet established dividend payer.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.576.0% undervalued
44 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
AN
andrei9868
Emerging Author
NOW logo
andrei9868 on ServiceNow ·

The Platform Turning Enterprise Chaos into Autonomous Workflows

Fair Value:US$17015.9% undervalued
11 users have followed this narrative
2 users have commented on this narrative
2 users have liked this narrative
JO
John_Eric
Emerging Author
VST logo
John_Eric on Vistra ·

Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here's the $472 Million Reason They Disagree.

Fair Value:US$291.8752.7% undervalued
6 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
HA
HarishPK
Emerging Author
EVER logo
HarishPK on EverQuote ·

EverQuote and an Asymmetric Investment Opportunity

Fair Value:US$36.0931.2% undervalued
4 users have followed this narrative
1 users have commented on this narrative
2 users have liked this narrative

Updated Narratives

WO
Womble
APP logo
Womble on AppLovin ·

AppLovin's Future Looks Bright with 19% Revenue Growth

Fair Value:US$331.946.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WO
Womble
NBIS logo
Womble on Nebius Group ·

Prepare for Nebius Group's Revenue to Soar by 49.8%

Fair Value:US$259.9723.2% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WO
Womble
NOW logo
Womble on ServiceNow ·

ServiceNow's 16% Revenue Growth Will Excite Future Investors

Fair Value:US$19024.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
373 users have followed this narrative
9 users have commented on this narrative
17 users have liked this narrative
JO
John_Eric
Emerging Author
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.2% undervalued
128 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9119.3% overvalued
217 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Trending Discussion